Proteins research bags 2018 Nobel Prize in Chemistry

The 2018 Nobel Prize in Chemistry is finally revealed. Researchers win the Nobel Prize for their work harnessing the power of evolution to develop proteins that solve humankind’s chemical problems. The Royal Swedish Academy of Sciences awarded the Prize with one half to Frances H. Arnold, at California Institute of Technology, Pasadena, US “for the directed evolution of enzymes,” and the other half jointly to George P. Smith at the University of Missouri, Columbia, US and Gregory P. Winter at the MRC Laboratory of Molecular Biology in Cambridge, UK “for the phage display of peptides and antibodies. Read More


Ineos announced plans to construct a world-scale propane dehydrogenation unit, together with the first gas cracker to be built in Europe for more than 20 years. After careful consideration, Ineos has selected McDermott’s Lummus Catofin Technology as the operating technology for its planned PDH unit and a license agreement has now been signed. In parallel, an agreement has been signed with Clariant for the long-term supply of catalyst for the unit. The PDH unit will have a nameplate capacity of 750ktpa of polymer grade propylene and is planned to be commissioned in 2023. Propylene from the asset will feed INEOS’ polypropylene units, as well as a number of other downstream propylene derivative businesses. Read More

AkzoNobel NV has completed the sale of the specialty chemicals business to The Carlyle Group and GIC for an enterprise value of €10.1 billion. “This is a key milestone in the history of AkzoNobel, creating a focused paints and coatings company, with market-leading positions, strong global brands, and a clear strategy to create value for all our stakeholders. This is also an important step for the specialty chemicals business and I would like to take this opportunity to say thank you to our colleagues and wish them a successful future with Carlyle and GIC,” Thierry Vanlancker, CEO of AkzoNobel. “I am delighted to assume my new role at specialty chemicals and look forward to working with the management team, Carlyle and GIC to deliver long-term success. Read More

Solvay SA has finalized an exclusive agreement with French biotech producer Deinove SA to commercialize ReGeN-oPhyt. ReGeN-oPhyt is a novel, natural active ingredient for skin-care products in North America and Asia. ReGeN-oPhyt is derived from phytoene, a colourless carotenoid used as a cutting-edge skin-care active to deliver antioxidant/anti-aging properties. ReGeN-oPhyt was developed using a state-of-the-art biotechnology platform based on the fermentation of natural sugars by extremophilic Deinococcus bacterium. Carotenoids are naturally occurring substances that fight oxidative stress in skin cells. Until now, nutrition was the only recognized logical source of phytoene for consumers. Read More